Your browser doesn't support javascript.
loading
Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes.
Pervjakova, Natalia; Moen, Gunn-Helen; Borges, Maria-Carolina; Ferreira, Teresa; Cook, James P; Allard, Catherine; Beaumont, Robin N; Canouil, Mickaël; Hatem, Gad; Heiskala, Anni; Joensuu, Anni; Karhunen, Ville; Kwak, Soo Heon; Lin, Frederick T J; Liu, Jun; Rifas-Shiman, Sheryl; Tam, Claudia H; Tam, Wing Hung; Thorleifsson, Gudmar; Andrew, Toby; Auvinen, Juha; Bhowmik, Bishwajit; Bonnefond, Amélie; Delahaye, Fabien; Demirkan, Ayse; Froguel, Philippe; Haller-Kikkatalo, Kadri; Hardardottir, Hildur; Hummel, Sandra; Hussain, Akhtar; Kajantie, Eero; Keikkala, Elina; Khamis, Amna; Lahti, Jari; Lekva, Tove; Mustaniemi, Sanna; Sommer, Christine; Tagoma, Aili; Tzala, Evangelia; Uibo, Raivo; Vääräsmäki, Marja; Villa, Pia M; Birkeland, Kåre I; Bouchard, Luigi; Duijn, Cornelia M; Finer, Sarah; Groop, Leif; Hämäläinen, Esa; Hayes, Geoffrey M; Hitman, Graham A.
Afiliação
  • Pervjakova N; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu 51010, Estonia.
  • Moen GH; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Borges MC; Diamantina Institute, The University of Queensland, Woolloongabba QLD 4102, Australia.
  • Ferreira T; K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  • Cook JP; Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.
  • Allard C; Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.
  • Beaumont RN; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Canouil M; Big Data Institute, Li Ka Shing Center for Health for Health Information and Discovery, Oxford University, Oxford, UK.
  • Hatem G; Department of Health Data Science, University of Liverpool, Liverpool, UK.
  • Heiskala A; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS), Universite de Sherbrooke, Quebec, Canada.
  • Joensuu A; Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, UK.
  • Karhunen V; Inserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille F-59000, France.
  • Kwak SH; University of Lille, Lille University Hospital, Lille F-59000, France.
  • Lin FTJ; Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund University Diabetes Centre, Malmö SE-20502, Sweden.
  • Liu J; Centre for Life-Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
  • Rifas-Shiman S; Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Tam CH; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Tam WH; Centre for Life-Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
  • Thorleifsson G; School of Public Health, Department of Epidemiology and Biostatistics, Imperial College London, St Mary's Hospital, London, UK.
  • Andrew T; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Auvinen J; Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
  • Bhowmik B; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Bonnefond A; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Delahaye F; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Demirkan A; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, The People's Republic of China.
  • Froguel P; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong SAR, The People's Republic of China.
  • Haller-Kikkatalo K; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Hardardottir H; Inserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille F-59000, France.
  • Hummel S; University of Lille, Lille University Hospital, Lille F-59000, France.
  • Hussain A; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Kajantie E; Centre for Life-Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
  • Keikkala E; Centre of Global Health Research, Diabetic Association of Bangladesh, Dhaka, Bangladesh.
  • Khamis A; Inserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille F-59000, France.
  • Lahti J; University of Lille, Lille University Hospital, Lille F-59000, France.
  • Lekva T; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Mustaniemi S; Inserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille F-59000, France.
  • Sommer C; University of Lille, Lille University Hospital, Lille F-59000, France.
  • Tagoma A; Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Tzala E; Section of Statistical Multi-omics, Department of Clinical and Experimental Research, University of Surrey, Surrey, UK.
  • Uibo R; Inserm U1283, CNRS UMR 8199, European Genomic Institute for Diabetes, Institut Pasteur de Lille, Lille F-59000, France.
  • Vääräsmäki M; University of Lille, Lille University Hospital, Lille F-59000, France.
  • Villa PM; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Birkeland KI; Department of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
  • Bouchard L; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Duijn CM; Livio Reykjavik, Reykjavik, Iceland.
  • Finer S; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany.
  • Groop L; Forschergruppe Diabetes, Technical University Munich, at Klinikum rechts der Isar, Munich, Germany.
  • Hämäläinen E; Centre of Global Health Research, Diabetic Association of Bangladesh, Dhaka, Bangladesh.
  • Hayes GM; Faculty of Health Sciences, Nord University, Bodø, Norway.
  • Hitman GA; Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.
Hum Mol Genet ; 31(19): 3377-3391, 2022 09 29.
Article em En | MEDLINE | ID: mdl-35220425
Gestational diabetes mellitus (GDM) is associated with increased risk of pregnancy complications and adverse perinatal outcomes. GDM often reoccurs and is associated with increased risk of subsequent diagnosis of type 2 diabetes (T2D). To improve our understanding of the aetiological factors and molecular processes driving the occurrence of GDM, including the extent to which these overlap with T2D pathophysiology, the GENetics of Diabetes In Pregnancy Consortium assembled genome-wide association studies of diverse ancestry in a total of 5485 women with GDM and 347 856 without GDM. Through multi-ancestry meta-analysis, we identified five loci with genome-wide significant association (P < 5 × 10-8) with GDM, mapping to/near MTNR1B (P = 4.3 × 10-54), TCF7L2 (P = 4.0 × 10-16), CDKAL1 (P = 1.6 × 10-14), CDKN2A-CDKN2B (P = 4.1 × 10-9) and HKDC1 (P = 2.9 × 10-8). Multiple lines of evidence pointed to the shared pathophysiology of GDM and T2D: (i) four of the five GDM loci (not HKDC1) have been previously reported at genome-wide significance for T2D; (ii) significant enrichment for associations with GDM at previously reported T2D loci; (iii) strong genetic correlation between GDM and T2D and (iv) enrichment of GDM associations mapping to genomic annotations in diabetes-relevant tissues and transcription factor binding sites. Mendelian randomization analyses demonstrated significant causal association (5% false discovery rate) of higher body mass index on increased GDM risk. Our results provide support for the hypothesis that GDM and T2D are part of the same underlying pathology but that, as exemplified by the HKDC1 locus, there are genetic determinants of GDM that are specific to glucose regulation in pregnancy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Pregnancy Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estônia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Pregnancy Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estônia País de publicação: Reino Unido